- November 18, 16:06 Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New
- November 18, 16:00 Access Advance Welcomes Xiaomi to HEVC Advance and VVC Advance Patent Pools as a Licensor and Licensee
- November 18, 15:30 Omdia: US FAST 80% Market Dominance Creates Breakthrough Opportunity for Korean Channels
- November 18, 15:30 Dilawer Farazi Returns to Loomis Sayles as Co-Head and Portfolio Manager on the Emerging Markets Debt Team
- November 18, 15:10 Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Korea Newswire sends your news to the 43,000 journalists in 7,000 media outlets in Korea via our exclusive distribution network.
Korea Newswire sends your news to the world, including 160 countries in 30 languages in partnership with Business Wire.



